Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

10.50
+0.24002.34%
Post-market: 10.500.00000.00%19:30 EDT
Volume:752.20K
Turnover:7.90M
Market Cap:652.67M
PE:-8.41
High:10.72
Open:10.15
Low:10.15
Close:10.26
52wk High:11.15
52wk Low:4.50
Shares:62.16M
Float Shares:55.78M
Volume Ratio:0.91
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2490
EPS(LYR):-1.5800
ROE:-24.37%
ROA:-16.41%
PB:2.55
PE(LYR):-6.65

Loading ...

Sagimet Making 'Good Progress' in Bringing Denifanstat to US Patients, Wedbush Securities Says

MT Newswires Live
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
Aug 12

Sagimet Highlights Q2 Results and Dermatology Focus Shift

TIPRANKS
·
Aug 11

Sagimet Biosciences Q2 EPS $(0.26) Misses $(0.25) Estimate

Benzinga Earnings
·
Aug 11

Sagimet Net Loss Widens to $14 Million in Q2 FY26; R&D Expense Climbs to $11.54 Million

Reuters
·
Aug 11

Sagimet Biosciences Q2 EPS USD -0.26

THOMSON REUTERS
·
Aug 11

Press Release: Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Dow Jones
·
Aug 11

Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

GlobeNewswire
·
Aug 04

Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up

TIPRANKS
·
Jul 25

Top Sagimet Executives Quietly Unlock Major Value in Recent Stock Moves

TIPRANKS
·
Jul 23

Sagimet Biosciences Director George Kemble Disposes of USD 140,548 in Common Shares

Reuters
·
Jul 23

Sagimet Biosciences Added to Russell Indexes

MT Newswires Live
·
Jun 30

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

GlobeNewswire
·
Jun 29

Sagimet Biosciences grants 34,300 inducement stock options to new hires

Reuters
·
Jun 23

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 23

Sagimet: Buy Rating Reiterated as Denifanstat Advances and $28 Price Target Remains Unchanged

TIPRANKS
·
Jun 18

Sagimet Biosciences Announces Board Changes and Director Elections

TIPRANKS
·
Jun 13

Sagimet Biosciences shareholders elect Class III directors at annual meeting

Reuters
·
Jun 13

Sagimet Biosciences Grants New Performance-Based Executive Equity Awards

TIPRANKS
·
Jun 04

Sagimet Biosciences grants CEO David Happel 300,000 stock options, 300,000 performance-based RSUs

Reuters
·
Jun 04